scispace - formally typeset
N

Nora D. Volkow

Researcher at National Institute on Drug Abuse

Publications -  1038
Citations -  121498

Nora D. Volkow is an academic researcher from National Institute on Drug Abuse. The author has contributed to research in topics: Dopamine & Addiction. The author has an hindex of 165, co-authored 958 publications receiving 107463 citations. Previous affiliations of Nora D. Volkow include National Institutes of Health & North Shore University Hospital.

Papers
More filters
Journal ArticleDOI

Improving Outcomes for Persons With Opioid Use Disorders: Buprenorphine Implants to Improve Adherence and Access to Care.

TL;DR: Prevention should address the major risk factors for opioid use, especially prescription practices for opioid analgesics that can minimize diversion, abuse, and addiction, and improved treatment for those with opioid use disorders.
Journal ArticleDOI

[18F]Haloperidol binding in baboon brain in vivo

TL;DR: The results indicate that the binding profile of [18F]haloperidol does not permit the selective examination of either dopamine D2 or sigma sites using PET.
Journal ArticleDOI

2-deoxy-2-[18F]fluoro-D-glucose and alternative radiotracers for positron emission tomography imaging using the human brain as a model.

TL;DR: Examples in which 18FDG is paired with another carbon-11- or fluorine-18-labeled radiotracer in the same subject to correlate neurotransmitter-specific effects with regional metabolic effects using the human brain as a model are highlighted.
Journal ArticleDOI

Enhanced neuronal and blunted hemodynamic reactivity to cocaine in the prefrontal cortex following extended cocaine access: optical imaging study in anesthetized rats.

TL;DR: The opposite changes in hemodynamics and neuronal responses in LgA rats indicate that these constitute distinct effects and suggest that the neuronal and not the vascular effects are associated with escalation of cocaine intake in addiction whereas its vascular effect in PFC might contribute to cognitive deficits that increase vulnerability to relapse.